Movatterモバイル変換


[0]ホーム

URL:


US20040222123A1 - Kit for pharmaceuticals - Google Patents

Kit for pharmaceuticals
Download PDF

Info

Publication number
US20040222123A1
US20040222123A1US10/429,766US42976603AUS2004222123A1US 20040222123 A1US20040222123 A1US 20040222123A1US 42976603 AUS42976603 AUS 42976603AUS 2004222123 A1US2004222123 A1US 2004222123A1
Authority
US
United States
Prior art keywords
kit
planner
supply
oral contraceptive
container
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/429,766
Inventor
Amy Niemann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Barr Pharmaceuticals Inc
Original Assignee
Barr Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Barr Laboratories IncfiledCriticalBarr Laboratories Inc
Priority to US10/429,766priorityCriticalpatent/US20040222123A1/en
Assigned to BARR LABORATORIES, INC.reassignmentBARR LABORATORIES, INC.ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).Assignors: NIEMANN, AMY C.
Priority to PCT/US2004/011543prioritypatent/WO2004108073A2/en
Publication of US20040222123A1publicationCriticalpatent/US20040222123A1/en
Abandonedlegal-statusCriticalCurrent

Links

Images

Classifications

Definitions

Landscapes

Abstract

The present invention is directed towards a kit to accompany a supply of a long-term use pharmaceutical. The kit includes at least a supply of a long-term use pharmaceutical, printed matter, and a pre-recorded media device. The kit may also include a planner and a reminder tool. The present invention also includes a container for storing at least the supply of the long-term use pharmaceutical, the printed matter, and the pre-recorded media device.

Description

Claims (29)

What is claimed is:
1. A kit to accompany a supply of a long-term use pharmaceutical, comprising:
a supply of a long-term use pharmaceutical;
printed matter;
a pre-recorded media device;
a planner;
a reminder tool; and
a container for storing at least said supply of said long-term use pharmaceutical, said printed matter, said pre-recorded visual media device, said planner, and said reminder tool.
2. The kit ofclaim 1, wherein said printed matter is one of a book, booklet, brochure or leaflet.
3. The kit ofclaim 1, wherein said pre-recorded media device is one of a DVD, a videotape cassette, a CD-ROM, an audiocassette or an audio compact disk.
4. The kit ofclaim 1, wherein said planner is one of a weekly planner, a monthly planner, a multi-month planner, a yearly planner, or a multi-year planner.
5. The kit ofclaim 1, wherein said reminder tool is one of a magnet, a permanent sticker, a removable sticker, an alarm, a watch, a clock or a calendar.
6. The kit ofclaim 1, wherein said container is a bag, a box or an envelope.
7. The kit ofclaim 1, wherein said long-term use pharmaceutical is a hormonal agent.
8. The kit ofclaim 7, wherein said hormonal agent is an oral contraceptive.
9. The kit ofclaim 8, wherein said oral contraceptive is designed for a regimen longer than a conventional 28-day regimen.
10. The kit ofclaim 9, wherein said oral contraceptive is designed for a 91-day regimen.
11. The kit ofclaim 1, wherein said supply is at least one package comprising more than one daily dose of said long-term use pharmaceutical.
12. The kit ofclaim 1, wherein said supply is at least one administrative device for continuous release of said long-term use pharmaceutical.
13. The kit ofclaim 1, wherein said container comprises an identifying means permanently affixed to an exterior of said container.
14. A kit to accompany a supply of a hormonal agent, comprising:
a supply of said hormonal agent;
printed matter; and
a pre-recorded media device.
15. The kit ofclaim 14, wherein said hormonal agent is an oral contraceptive.
16. The kit ofclaim 15, wherein said oral contraceptive is designed for a regimen longer than a conventional 28-day regimen.
17. The kit ofclaim 16, wherein said oral contraceptive is designed for a 91-day regimen.
18. The kit ofclaim 14, wherein said printed matter is one of a book, booklet, brochure or leaflet.
19. The kit ofclaim 14, wherein said pre-recorded media device is one of a DVD, a videotape cassette, a CD-ROM, an audiocassette or an audio compact disk.
20. The kit ofclaim 14, wherein said supply is at least one package comprising more than one daily dose of said hormonal agent.
21. The kit ofclaim 14, wherein said supply is at least one administrative device for continuous release of said hormonal agent.
22. The kit ofclaim 14, further comprising one or more components selected from the group comprising a planner, a reminder tool and a container.
23. The kit ofclaim 22, wherein said planner is one of a weekly planner, a monthly planner, a multi-month planner, a yearly planner, or a multi-year planner.
24. The kit ofclaim 22, wherein said reminder tool is one of a magnet, a permanent sticker, a removable sticker, an alarm, a watch, a clock or a calendar.
25. The kit ofclaim 22, wherein said container is a bag, a box or an envelope.
26. The kit ofclaim 22, wherein said container comprises an identifying means permanently affixed to an exterior of said container.
27. A kit to accompany a supply an oral contraceptive, comprising:
a supply of an oral contraceptive;
printed matter;
a pre-recorded videotape cassette;
a planner;
a reminder tool; and
a bag for storing at least said supply of an oral contraceptive, said printed matter, said pre-recorded videocassette, said planner, and said reminder tool.
28. The kit ofclaim 27, wherein said oral contraceptive is designed for a regimen longer than a conventional 28-day regimen.
29. The kit ofclaim 28, wherein said oral contraceptive is designed for a 91-day regimen.
US10/429,7662003-05-062003-05-06Kit for pharmaceuticalsAbandonedUS20040222123A1 (en)

Priority Applications (2)

Application NumberPriority DateFiling DateTitle
US10/429,766US20040222123A1 (en)2003-05-062003-05-06Kit for pharmaceuticals
PCT/US2004/011543WO2004108073A2 (en)2003-05-062004-04-14Kit for pharmaceuticals

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
US10/429,766US20040222123A1 (en)2003-05-062003-05-06Kit for pharmaceuticals

Publications (1)

Publication NumberPublication Date
US20040222123A1true US20040222123A1 (en)2004-11-11

Family

ID=33416115

Family Applications (1)

Application NumberTitlePriority DateFiling Date
US10/429,766AbandonedUS20040222123A1 (en)2003-05-062003-05-06Kit for pharmaceuticals

Country Status (2)

CountryLink
US (1)US20040222123A1 (en)
WO (1)WO2004108073A2 (en)

Cited By (16)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US20040220152A1 (en)*2003-05-022004-11-04Ben-Maimon Carole S.Methods of hormonal treatment utilizing extended cycle contraceptive regimens
US20050143359A1 (en)*2003-07-162005-06-30Bell Robert G.Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
USD535469S1 (en)2005-10-172007-01-23Richelle NassosFirst aid case
USRE39861E1 (en)1997-06-232007-09-25Duramed Pharmaceuticals, Inc.Methods of extended use oral contraception
US20080064670A1 (en)*2001-12-052008-03-13Duramed Pharmaceuticals, Inc.Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US20080121554A1 (en)*2006-11-292008-05-29Richard TownsendPortable medical kit
US20110203949A1 (en)*2008-11-032011-08-25Mohammed Ridha ChakrounContraception kit
US8415332B2 (en)2004-10-072013-04-09TEVA Woman's Health, Inc.Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
US20130203710A1 (en)*2012-02-062013-08-08William L. PridgenAntiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
US8546450B1 (en)2009-03-312013-10-01Nuvo Research Inc.Treatment of pain with topical diclofenac compounds
US8563613B2 (en)2006-10-172013-10-22Nuvo Research Inc.Diclofenac topical formulation
US20130317009A1 (en)*2012-05-182013-11-28Gruenenthal GmbhPharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and an Anticonvulsant
US8618164B2 (en)2009-03-312013-12-31Nuvo Research Inc.Treatment of pain with topical diclofenac compounds
US9320725B2 (en)2012-05-182016-04-26Gruenenthal GmbhPharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
JP2017205287A (en)*2016-05-182017-11-24株式会社エムティーアイOral contraceptive taking scheduling system, oral contraceptive taking scheduling method, and program
US10328055B2 (en)2012-05-182019-06-25Gruenenthal GmbhPharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indo]-4-amine and antidepressants

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
TW200727920A (en)*2005-06-212007-08-01Organon NvNew regimens for oral monophasic contraceptives

Citations (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4817819A (en)*1985-12-191989-04-04Berlex Laboratories, Inc.Container for tablets
US5351818A (en)*1992-08-201994-10-04Yousef DaneshvarMedicine box
US5377841A (en)*1993-12-101995-01-03Carter-Wallace, Inc.Sleep therapy package
US5544753A (en)*1994-12-081996-08-13Monica; Julianne H.Kit for the care of back ailments
US5833330A (en)*1997-12-241998-11-10Kos; Joy Y.Personal organizer and medical health care delivery facilitation device
US5884771A (en)*1997-09-221999-03-23Mccormick; Diane L.Disposable hygiene carrier kit
US5931304A (en)*1998-01-201999-08-03Hammond; David A.First aid kit and method of replenishing
US6039208A (en)*1994-07-292000-03-21Ortho Pharmaceutical CorporationVariable day start tablet dispenser
US6156742A (en)*1996-05-162000-12-05Gynetics Inc.Emergency contraceptive kit
US6375956B1 (en)*1999-07-222002-04-23Drugtech CorporationStrip pack
US6390327B1 (en)*1999-12-212002-05-21Bradley Allen CornellMedicine container with alarm
US6479475B1 (en)*1996-07-262002-11-12WyethOral contraceptive
US20030139381A1 (en)*2001-12-052003-07-24Barr Laboratories, Inc.Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US5544743A (en)*1994-04-041996-08-13Hong; Bum-KiGolf bag

Patent Citations (13)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US4817819A (en)*1985-12-191989-04-04Berlex Laboratories, Inc.Container for tablets
US5351818A (en)*1992-08-201994-10-04Yousef DaneshvarMedicine box
US5377841A (en)*1993-12-101995-01-03Carter-Wallace, Inc.Sleep therapy package
US6039208A (en)*1994-07-292000-03-21Ortho Pharmaceutical CorporationVariable day start tablet dispenser
US5544753A (en)*1994-12-081996-08-13Monica; Julianne H.Kit for the care of back ailments
US6156742A (en)*1996-05-162000-12-05Gynetics Inc.Emergency contraceptive kit
US6479475B1 (en)*1996-07-262002-11-12WyethOral contraceptive
US5884771A (en)*1997-09-221999-03-23Mccormick; Diane L.Disposable hygiene carrier kit
US5833330A (en)*1997-12-241998-11-10Kos; Joy Y.Personal organizer and medical health care delivery facilitation device
US5931304A (en)*1998-01-201999-08-03Hammond; David A.First aid kit and method of replenishing
US6375956B1 (en)*1999-07-222002-04-23Drugtech CorporationStrip pack
US6390327B1 (en)*1999-12-212002-05-21Bradley Allen CornellMedicine container with alarm
US20030139381A1 (en)*2001-12-052003-07-24Barr Laboratories, Inc.Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology

Cited By (57)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
USRE39861E1 (en)1997-06-232007-09-25Duramed Pharmaceuticals, Inc.Methods of extended use oral contraception
US7615545B2 (en)2001-12-052009-11-10Duramed Pharmaceuticals, Inc.Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US20100298279A1 (en)*2001-12-052010-11-25Bell Robert GOral Contraceptives to Prevent Pregnancy and Diminish Premenstrual Symptomatology
US8338396B2 (en)2001-12-052012-12-25Teva Women's Health, Inc.Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US20080064670A1 (en)*2001-12-052008-03-13Duramed Pharmaceuticals, Inc.Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US8680084B2 (en)2001-12-052014-03-25Teva Women's Health, Inc.Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US7858605B2 (en)2001-12-052010-12-28Teva Women's Health, Inc.Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology
US20040220152A1 (en)*2003-05-022004-11-04Ben-Maimon Carole S.Methods of hormonal treatment utilizing extended cycle contraceptive regimens
US7772219B2 (en)2003-05-022010-08-10Teva Women's Health, Inc.Methods of hormonal treatment utilizing extended cycle contraceptive regimens
US7855190B2 (en)2003-07-162010-12-21Teva Women's Health, Inc.Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20110124611A1 (en)*2003-07-162011-05-26Teva Women's Health, Inc.Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US20050143359A1 (en)*2003-07-162005-06-30Bell Robert G.Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration
US8450299B2 (en)2004-10-072013-05-28Teva Womans's Health, Inc.Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
US8415332B2 (en)2004-10-072013-04-09TEVA Woman's Health, Inc.Methods of hormonal treatment utilizing ascending-dose extended cycle regimens
USD535469S1 (en)2005-10-172007-01-23Richelle NassosFirst aid case
US9101591B2 (en)2006-10-172015-08-11Hznp LimitedDiclofenac topical formulation
US9066913B2 (en)2006-10-172015-06-30Hznp LimitedDiclofenac topical formulation
US9339551B2 (en)2006-10-172016-05-17Hznp LimitedDiclofenac topical formulation
US8563613B2 (en)2006-10-172013-10-22Nuvo Research Inc.Diclofenac topical formulation
US9220784B2 (en)2006-10-172015-12-29Hznp LimitedDiclofenac topical formulation
US9168304B2 (en)2006-10-172015-10-27Hznp LimitedDiclofenac topical formulation
US9339552B2 (en)2006-10-172016-05-17Hznp LimitedDiclofenac topical formulation
US9168305B2 (en)2006-10-172015-10-27Hznp LimitedDiclofenac topical formulation
US9539335B2 (en)2006-10-172017-01-10Hznp LimitedDiclofenac topical formulation
US8871809B2 (en)2006-10-172014-10-28Nuvo Research Inc.Diclofenac topical formulation
US20080121554A1 (en)*2006-11-292008-05-29Richard TownsendPortable medical kit
US20110203949A1 (en)*2008-11-032011-08-25Mohammed Ridha ChakrounContraception kit
US8777014B2 (en)*2008-11-032014-07-15Mohammed Ridha ChakrounContraception kit
US9375412B2 (en)2009-03-312016-06-28Hznp LimitedTreatment of pain with topical diclofenac
US9415029B2 (en)2009-03-312016-08-16Hznp LimitedTreatment of pain with topical diclofenac
US9132110B2 (en)2009-03-312015-09-15Hznp LimitedTreatment of pain with topical diclofenac
US8741956B2 (en)*2009-03-312014-06-03Nuvo Research Inc.Treatment of pain with topical diclofenac
US8618164B2 (en)2009-03-312013-12-31Nuvo Research Inc.Treatment of pain with topical diclofenac compounds
US9370501B2 (en)2009-03-312016-06-21Hznp LimitedTreatment of pain with topical diclofenac
US10058519B2 (en)2009-03-312018-08-28Hznp LimitedTreatment of pain with topical diclofenac
US8546450B1 (en)2009-03-312013-10-01Nuvo Research Inc.Treatment of pain with topical diclofenac compounds
US9682051B2 (en)2012-02-062017-06-20Innovative Med Concepts, LLCAcyclovir and meloxicam combination therapy for functional somatic syndromes
US10251853B2 (en)2012-02-062019-04-09Innovative Med Concepts, LLCSynergistic famciclovir and celecoxib combination therapy for functional somatic syndromes
US9259405B2 (en)2012-02-062016-02-16Innovative Med Concepts, LLCMethod of treating functional somatic syndromes with combination of famciclovir and diclofenac
US11096912B2 (en)2012-02-062021-08-24Virios Therapeutics, Inc.Valaciclovir and celecoxib combination for functional somatic syndromes
US9173863B2 (en)2012-02-062015-11-03Innovative Med Concepts, LLCAntiviral compound and COX-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
US9040546B2 (en)2012-02-062015-05-26Innovative Med Concepts, LLCMethod of treating functional somatic syndromes with combination of famciclovir and celecoxib
US8987282B2 (en)2012-02-062015-03-24Innovative Med Concepts, LLCAcyclovir and meloxicam combination therapy for functional somatic syndromes
US8809351B2 (en)*2012-02-062014-08-19Innovative Med Concepts, LLC.Antiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
US10632087B2 (en)2012-02-062020-04-28Innovative Med Concepts, LLC.Famciclovir and meloxicam combination therapy for functional somatic syndromes
US9642824B2 (en)2012-02-062017-05-09Innovative Med Concepts, LLCValaciclovir and diclofenac combination therapy for functional somatic syndromes
US20130203710A1 (en)*2012-02-062013-08-08William L. PridgenAntiviral compound and cox-2 inhibitor combination therapy for functional somatic syndromes, including combination of famciclovir and celecoxib
US10543184B2 (en)2012-02-062020-01-28Innovative Med Concepts, LLCMethod to treat functional somatic syndromes with combination of aciclovir and celecoxib
US10034846B2 (en)2012-02-062018-07-31Innovative Med Concepts, LLCFamciclovir and celecoxib combination therapy for functional somatic syndromes
US9980932B2 (en)2012-02-062018-05-29Innovative Med Concepts, LLCValaciclovir and meloxicam combination therapy for functional somatic syndromes
US20130317009A1 (en)*2012-05-182013-11-28Gruenenthal GmbhPharmaceutical Composition Comprising (1r,4r)-6'-fluoro-N, N-dimethyl-4-phenyl-4,9' -dihydro-3'H-spiro[cyclohexane-1,1' -pyrano[3,4,b]indol]-4-amine and an Anticonvulsant
US9320725B2 (en)2012-05-182016-04-26Gruenenthal GmbhPharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
US10328055B2 (en)2012-05-182019-06-25Gruenenthal GmbhPharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indo]-4-amine and antidepressants
AU2013262078B2 (en)*2012-05-182017-10-26Grünenthal GmbHPharmaceutical composition comprising (1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano [3,4,b]indol]-4-amine and an anticonvulsant
US9629825B2 (en)2012-05-182017-04-25Gruenenthal GmbhPharmaceutical composition comprising (1r,4r)-6′-fluoro-N,N-dimethyl-4-phenyl-4′,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and a gabapentinoid
US9345689B2 (en)*2012-05-182016-05-24Gruenenthal GmbhPharmaceutical composition comprising (1r,4r)-6′-fluoro-N, N-dimethyl-4-phenyl-4,9′-dihydro-3′H-spiro[cyclohexane-1,1′-pyrano[3,4,b]indol]-4-amine and an anticonvulsant
JP2017205287A (en)*2016-05-182017-11-24株式会社エムティーアイOral contraceptive taking scheduling system, oral contraceptive taking scheduling method, and program

Also Published As

Publication numberPublication date
WO2004108073A2 (en)2004-12-16
WO2004108073A3 (en)2005-04-28

Similar Documents

PublicationPublication DateTitle
US20040222123A1 (en)Kit for pharmaceuticals
CramerEnhancing patient compliance in the elderly: role of packaging aids and monitoring
US6550618B2 (en)Medicine dispensing apparatus
US5031937A (en)Pictorial guidance/reminder system for medication
US6371297B1 (en)Medication dosage regulation apparatus
CA2399901C (en)Weight-specific elixir dosage calculation reference
US20100211531A1 (en)Patient compliance system and method to promote patient compliance
US7926850B1 (en)Method for managing multiple medications
US20020066691A1 (en)Therapy pack
US20050109658A1 (en)Medication compliance and management device
US7240793B2 (en)Method and apparatus aiding in the management of multiple medications
Tatro et al.Online drug interaction surveillance
MkeleThe role of the pharmacist in TB management
JP3836308B2 (en) Pharmaceutical packaging
JP3068718U (en) Medicine bag
Durant et al.Wisconsin information service and medication distribution
FinchamMethods to Impact Patient Compliance
JPS63199689A (en)Recipe indicating card for internal medicine
KR200360542Y1 (en)Medicine receipt case having Date discernment part for one times
JP2001258999A (en)Medication calendar
JP2003070878A (en)Instruction manual of paper envelope and drug such as drug information or the like
JP3054466U (en) Notebook
Lal et al.Informing patients about drugs
TWM664200U (en) Partitioned medicine information bag
AltschulerHereditary somnambulism in Dracula

Legal Events

DateCodeTitleDescription
ASAssignment

Owner name:BARR LABORATORIES, INC., NEW YORK

Free format text:ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:NIEMANN, AMY C.;REEL/FRAME:014042/0352

Effective date:20030727

STCBInformation on status: application discontinuation

Free format text:ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION


[8]ページ先頭

©2009-2025 Movatter.jp